2. Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Lee KH,
et al. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. PLoS One 2013;8:e64271.
3. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG,
et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363:1693–1703.
5. Lee WS, Kim HY, Seok JY, Jang HH, Park YH, Kim SY,
et al. Genomic profiling of patient-derived colon cancer xenograft models. Medicine (Baltimore) 2014;93:e298.
6. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM,
et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 2009;69:3364–3373.
7. John T, Kohler D, Pintilie M, Yanagawa N, Pham NA, Li M,
et al. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer. Clin Cancer Res 2011;17:134–141.
8. Gu Z, Jiang J, Yan Y, Tan T, Yu T, Liu Z,
et al. Evaluation of the correlations between patient-derived xenograft (PDX) model-based mouse trials and cancer patient-based clinical trials. J Clin Oncol 2017;35:e23140.
9. Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A,
et al. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res 2008;14:6456–6468.
13. Rathi V, Wright G, Constantin D, Chang S, Pham H, Jones K,
et al. Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens. Pathology 2017;49:75–82.
14. Jung SH, Kim MS, Lee SH, Park HC, Choi HJ, Maeng L,
et al. Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. Proc Natl Acad Sci U S A 2016;113:10672–10677.
16. Hao C, Wang L, Peng S, Cao M, Li H, Hu J,
et al. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett 2015;357:179–185.